News
Latest News
Consultation: Kava Pilot Phase 2: Allowing the commercial importation of kava
5 August 2020
Submissions received for Kava Pilot Phase 2
Reforms to Medicinal Cannabis Scheme Fees and Charges
27 July 2020
Changes to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020
Import restrictions: Kava and Khat
8 July 2020
Update on the import of Kava
Australian Government proposes strengthening its stance against e-cigarettes containing vaporiser nicotine
29 June 2020
From 1 January 2021, proposed regulations would prohibit the importation of e-cigarettes containing vaporiser nicotine.
Guidance Note – Sponsored Import and Supply of Unregistered Medicinal Cannabis Products – Customs (Prohibited Imports) Regulations 1956
21 April 2020
Update to guidance on Sponsored Import and Supply of Unregistered Medicinal Cannabis Products
Import and export
20 April 2020
Update to guidance on import and export of medicial cannabis
Consultation: Medicinal Cannabis Cost Recovery Framework
13 March 2020
The Office of Drug Control (ODC) is seeking comments from interested parties on the proposed Medicinal Cannabis Cost Recovery Framework. Closing date: 20 March 2020
Health Products Regulation Group: Regulatory Science Strategy, 2020-2025
16 January 2020
Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
Implementation of the Review of the Narcotic Drugs Act 1967 (Cth)
17 December 2019
The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967
Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967
5 September 2019
Professor McMillan's Final Report on the Review of the Act was tabled in Parliament on Thursday 5 September 2019